SRT3 logo

Sartorius Aktiengesellschaft Stock Price

XTRA:SRT3 Community·€14.3b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 12 Fair Values set on narratives written by author

SRT3 Share Price Performance

€229.00
-6.40 (-2.72%)
26.1% undervalued intrinsic discount
€310.00
Fair Value
€229.00
-6.40 (-2.72%)
26.1% undervalued intrinsic discount
€310.00
Fair Value
Price €229.00
AnalystHighTarget €310.00
AnalystConsensusTarget €257.25
AnalystLowTarget €175.00

SRT3 Community Narratives

AnalystHighTarget·Updated
Fair Value €310 26.1% undervalued intrinsic discount

Cell And Gene Therapies Will Expand Secular Bioproduction

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystConsensusTarget·Updated
Fair Value €260.05 11.9% undervalued intrinsic discount

Advanced Biologic Adoption Will Expand Global Reach

0users have liked this narrative
0users have commented on this narrative
7users have followed this narrative
AnalystLowTarget·Updated
Fair Value €191.2 19.8% overvalued intrinsic discount

Rising Tariffs, Regulatory Hurdles And Cost Pressures Will Squeeze Margins

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative

SRT3 Community Fair Values

Recent SRT3 News & Updates

Sartorius Aktiengesellschaft Key Details

€3.5b

Revenue

€1.9b

Cost of Revenue

€1.6b

Gross Profit

€1.5b

Other Expenses

€104.1m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Oct 16, 2025
Earnings per share (EPS)
1.51
Gross Margin
45.76%
Net Profit Margin
3.00%
Debt/Equity Ratio
117.2%

Sartorius Aktiengesellschaft Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Reasonable growth potential with proven track record.

1 Risk
3 Rewards

About SRT3

Founded
1870
Employees
13685
CEO
Michael Grosse
WebsiteView website
www.sartorius.com

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors; software apps for bioreactors and cell culture shake flasks; fermenters; cell culture media, biolayer interferometry, microbiological testing, and fluid management products; buffers; reagents; plasmids; cellcelector flexs, incubator flowboxes, nanowell arrays, and capillaries and tips; high-throughput screening by cytometry; ultrafiltration solutions; syringe, membrane, glass and quartz microfiber, clarification, syringeless, and in-line filters; and lab chromatography, and filters and blotting papers. It also provides live-cell analysis systems, reagents and consumables, and support and services; live-cell imaging and analysis software; contract manufacturing and integration; OEM membranes and devices, weigh cells, and data analytics; connectivity, and pipetting and dispensing products; electronic and mechanical pipettes, pipette tips, bottle-top dispensers, and pipette controllers and accessories; process automation platform and software, sensors and analyzers, biomolecule analysis tools, and data analytics software; chromatography consumables, columns, and systems; and surface plasmon resonance and process filtration products. The company offers water purification systems; lab data and fleet management software; lab balances, pipette calibration, mass comparators and metrology, moisture analyzers, weights and weight sets, paint mixing solutions, and weighing accessories; and bioprocess consulting and engineering, biologics testing, cell culture media, instrument, octet service and support, and validation services. It serves the life science research, biopharmaceutical manufacturing, cell and gene therapy, and applied industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

German Market Performance

  • 7 Days: 2.6%
  • 3 Months: -0.3%
  • 1 Year: 14.7%
  • Year to Date: 13.3%
Over the last 7 days, the market has risen 2.6%, driven by gains in every sector, especially the Industrials sector. In the last year, the market has climbed 15%. Looking forward, earnings are forecast to grow by 17% annually. Market details ›